An unusual complication of peritoneal dialysis

Article Type
Article
Changed
Tue, 05/01/2018 - 08:11
Display Headline
An unusual complication of peritoneal dialysis
Author(s)
Mohamad Hanouneh, MD
Pranav Damera
Mehrdad Fetrat, MBBS, MD
Duvuru Geetha, MD

A 45-year-old man with end-stage renal disease secondary to hypertension presented with abdominal pain, nausea, vomiting, and fever. He had been on peritoneal dialysis for 15 years.

Results of initial laboratory testing were as follows:

  • Sodium 137 mmol/L (reference range 136–144)
  • Potassium 3.7 mmol/L (3.5–5.0)
  • Bicarbonate 31 mmol/L (22–30)
  • Creatinine 17.5 mg/dL (0.58–0.96)
  • Blood urea nitrogen 57 mg/dL (7–21)
  • Lactic acid 1.7 mmol/L (0.5–2.2)
  • White blood cell count 14.34 × 109/L (3.70–11.0).

Blood cultures were negative. Peritoneal fluid analysis showed a white blood cell count of 1.2 × 109/L (reference range < 0.5 × 109/L) with 89% neutrophils, and an amylase level less than 3 U/L (reference range < 100). Fluid cultures were positive for coagulase-negative staphylococci and Staphylococcus epidermidis.

Figure 1. Computed tomography showed diffuse parietal and visceral peritoneal calcifications encasing the small-bowel loops (arrows), consistent with encapsulating peritoneal sclerosis.
Computed tomography (CT) showed diffuse parietal and visceral peritoneal calcifications encasing the small-bowel loops, consistent with encapsulating peritoneal sclerosis (Figure 1). His peritoneal dialysis catheter was removed, and he was transitioned to hemodialysis. He was discharged on a course of antibiotics and was started on prednisone and tamoxifen.

Figure 2. Several months later, computed tomography showed dilated small-bowel loops indicative of small-bowel obstruction (red arrows) and pneumoperitoneum (yellow arrow).
He presented again a few months later with abdominal pain. At that time, CT (Figure 2) demonstrated dilated small-bowel loops indicative of small-bowel obstruction and pneumoperitoneum consistent with bowel perforation. He declined surgical treatment and was referred for hospice care.

CAUSES AND CLINICAL FEATURES

Encapsulating peritoneal sclerosis is a devastating complication of peritoneal dialysis, occurring in 3% of patients on peritoneal dialysis. The mortality rate is above 40%.1,2 It is characterized by an initial inflammatory phase followed by extensive intraperitoneal fibrosis and encasement of bowel. Causes include prolonged exposure to peritoneal dialysis or glucose degradation products, a history of severe peritonitis, use of acetate as a dialysate buffer, and reaction to medications such as beta-blockers.3

Clinical features result from inflammation, ileus, and peritoneal adhesions and include abdominal pain, nausea, and vomiting. A high peritoneal transport rate, which often heralds development of encapsulating peritoneal sclerosis, leads to failure of ultrafiltration and to fluid retention.

CT is recommended for diagnosis and demonstrates peritoneal calcification with bowel thickening and dilation.

TREATMENT

Treatment entails stopping peritoneal dialysis, changing to hemodialysis, bowel rest, and corticosteroids. Successful treatment has been reported with a combination of corticosteroids and azathioprine.4,5 A retrospective study showed that adding the antifibrotic agent tamoxifen was associated with a decrease in the mortality rate.6 Bowel obstruction is a common complication, and surgery may be indicated. Enterolysis is a new surgical technique that has shown improved outcomes.7         

References
  1. Kawaguchi Y, Saito A, Kawanishi H, et al. Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures. Perit Dial Int 2005; 25(suppl 4):S83–S95. pmid:16300277
  2. Lee HY, Kim BS, Choi HY, et al. Sclerosing encapsulating peritonitis as a complication of long-term continuous ambulatory peritoneal dialysis in Korea. Nephrology (Carlton) 2003; 8(suppl 2):S33–S39. doi:10.1046/J.1440-1797.8.S.11.X
  3. Kawaguchi Y, Tranaeus A. A historical review of encapsulating peritoneal sclerosis. Perit Dial Int 2005; 25(suppl 4):S7–S13. pmid:16300267
  4. Martins LS, Rodrigues AS, Cabrita AN, Guimaraes S. Sclerosing encapsulating peritonitis: a case successfully treated with immunosuppression. Perit Dial Int 1999; 19(5):478–481. pmid:11379862
  5. Wong CF, Beshir S, Khalil A, Pai P, Ahmad R. Successful treatment of encapsulating peritoneal sclerosis with azathioprine and prednisolone. Perit Dial Int 2005; 25(3):285–287. pmid:15981777
  6. Korte MR, Fieren MW, Sampimon DE, Lingsma HF, Weimar W, Betjes MG; investigators of the Dutch Multicentre EPS Study. Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study. Nephrol Dial Transplant 2011; 26(2):691–697. doi:10.1093/ndt/gfq362
  7. Kawanishi H, Watanabe H, Moriishi M, Tsuchiya S. Successful surgical management of encapsulating peritoneal sclerosis. Perit Dial Int 2005; 25(suppl 4):S39–S47. pmid:16300271
Article PDF
hanouneh_peritonealdialysis.pdf
Author and Disclosure Information

Mohamad Hanouneh, MD
Nephrology Fellow, Department of Medicine, Division of Nephrology, Johns Hopkins University, Baltimore, MD

Pranav Damera
University of Maryland-College Park, College Park, MD

Mehrdad Fetrat, MBBS, MD
Instructor of Radiology and Radiological Science, Department of Radiology, Johns Hopkins University, Baltimore, MD

Duvuru Geetha, MD
Associate Professor of Medicine, Department of Medicine, Division of Nephrology, Johns Hopkins University, Baltimore, MD

Address: Mohamad Hanouneh, MD, Department of Medicine, Division of Nephrology, Johns Hopkins University, 1830 E. Monument Street, Room 416, Baltimore, MD 21287; mhanoun1@jhmi.edu

Dr. Geetha has disclosed consulting for ChemoCentryx and Genentech.

Issue
Cleveland Clinic Journal of Medicine - 85(5)
Publications
Cleveland Clinic Journal of Medicine
Topics
Nephrology
Gastroenterology
Imaging
Page Number
352, 354
Legacy Keywords
peritoneal dialysis, end-stage renal disease, ESRD, encapsulating peritoneal sclerosis, computed tomography, CT, Mohamad Hanouneh, Pranav Damera, Mehrdad Fetrat, Duvuru Geetha
Sections
The Clinical Picture
Author(s)
Mohamad Hanouneh, MD
Pranav Damera
Mehrdad Fetrat, MBBS, MD
Duvuru Geetha, MD
Author(s)
Mohamad Hanouneh, MD
Pranav Damera
Mehrdad Fetrat, MBBS, MD
Duvuru Geetha, MD
Author and Disclosure Information

Mohamad Hanouneh, MD
Nephrology Fellow, Department of Medicine, Division of Nephrology, Johns Hopkins University, Baltimore, MD

Pranav Damera
University of Maryland-College Park, College Park, MD

Mehrdad Fetrat, MBBS, MD
Instructor of Radiology and Radiological Science, Department of Radiology, Johns Hopkins University, Baltimore, MD

Duvuru Geetha, MD
Associate Professor of Medicine, Department of Medicine, Division of Nephrology, Johns Hopkins University, Baltimore, MD

Address: Mohamad Hanouneh, MD, Department of Medicine, Division of Nephrology, Johns Hopkins University, 1830 E. Monument Street, Room 416, Baltimore, MD 21287; mhanoun1@jhmi.edu

Dr. Geetha has disclosed consulting for ChemoCentryx and Genentech.

Author and Disclosure Information

Mohamad Hanouneh, MD
Nephrology Fellow, Department of Medicine, Division of Nephrology, Johns Hopkins University, Baltimore, MD

Pranav Damera
University of Maryland-College Park, College Park, MD

Mehrdad Fetrat, MBBS, MD
Instructor of Radiology and Radiological Science, Department of Radiology, Johns Hopkins University, Baltimore, MD

Duvuru Geetha, MD
Associate Professor of Medicine, Department of Medicine, Division of Nephrology, Johns Hopkins University, Baltimore, MD

Address: Mohamad Hanouneh, MD, Department of Medicine, Division of Nephrology, Johns Hopkins University, 1830 E. Monument Street, Room 416, Baltimore, MD 21287; mhanoun1@jhmi.edu

Dr. Geetha has disclosed consulting for ChemoCentryx and Genentech.

Article PDF
hanouneh_peritonealdialysis.pdf
Article PDF
hanouneh_peritonealdialysis.pdf
Related Articles
Managing advanced chronic kidney disease: A primary care guide

A 45-year-old man with end-stage renal disease secondary to hypertension presented with abdominal pain, nausea, vomiting, and fever. He had been on peritoneal dialysis for 15 years.

Results of initial laboratory testing were as follows:

  • Sodium 137 mmol/L (reference range 136–144)
  • Potassium 3.7 mmol/L (3.5–5.0)
  • Bicarbonate 31 mmol/L (22–30)
  • Creatinine 17.5 mg/dL (0.58–0.96)
  • Blood urea nitrogen 57 mg/dL (7–21)
  • Lactic acid 1.7 mmol/L (0.5–2.2)
  • White blood cell count 14.34 × 109/L (3.70–11.0).

Blood cultures were negative. Peritoneal fluid analysis showed a white blood cell count of 1.2 × 109/L (reference range < 0.5 × 109/L) with 89% neutrophils, and an amylase level less than 3 U/L (reference range < 100). Fluid cultures were positive for coagulase-negative staphylococci and Staphylococcus epidermidis.

Figure 1. Computed tomography showed diffuse parietal and visceral peritoneal calcifications encasing the small-bowel loops (arrows), consistent with encapsulating peritoneal sclerosis.
Computed tomography (CT) showed diffuse parietal and visceral peritoneal calcifications encasing the small-bowel loops, consistent with encapsulating peritoneal sclerosis (Figure 1). His peritoneal dialysis catheter was removed, and he was transitioned to hemodialysis. He was discharged on a course of antibiotics and was started on prednisone and tamoxifen.

Figure 2. Several months later, computed tomography showed dilated small-bowel loops indicative of small-bowel obstruction (red arrows) and pneumoperitoneum (yellow arrow).
He presented again a few months later with abdominal pain. At that time, CT (Figure 2) demonstrated dilated small-bowel loops indicative of small-bowel obstruction and pneumoperitoneum consistent with bowel perforation. He declined surgical treatment and was referred for hospice care.

CAUSES AND CLINICAL FEATURES

Encapsulating peritoneal sclerosis is a devastating complication of peritoneal dialysis, occurring in 3% of patients on peritoneal dialysis. The mortality rate is above 40%.1,2 It is characterized by an initial inflammatory phase followed by extensive intraperitoneal fibrosis and encasement of bowel. Causes include prolonged exposure to peritoneal dialysis or glucose degradation products, a history of severe peritonitis, use of acetate as a dialysate buffer, and reaction to medications such as beta-blockers.3

Clinical features result from inflammation, ileus, and peritoneal adhesions and include abdominal pain, nausea, and vomiting. A high peritoneal transport rate, which often heralds development of encapsulating peritoneal sclerosis, leads to failure of ultrafiltration and to fluid retention.

CT is recommended for diagnosis and demonstrates peritoneal calcification with bowel thickening and dilation.

TREATMENT

Treatment entails stopping peritoneal dialysis, changing to hemodialysis, bowel rest, and corticosteroids. Successful treatment has been reported with a combination of corticosteroids and azathioprine.4,5 A retrospective study showed that adding the antifibrotic agent tamoxifen was associated with a decrease in the mortality rate.6 Bowel obstruction is a common complication, and surgery may be indicated. Enterolysis is a new surgical technique that has shown improved outcomes.7         

A 45-year-old man with end-stage renal disease secondary to hypertension presented with abdominal pain, nausea, vomiting, and fever. He had been on peritoneal dialysis for 15 years.

Results of initial laboratory testing were as follows:

  • Sodium 137 mmol/L (reference range 136–144)
  • Potassium 3.7 mmol/L (3.5–5.0)
  • Bicarbonate 31 mmol/L (22–30)
  • Creatinine 17.5 mg/dL (0.58–0.96)
  • Blood urea nitrogen 57 mg/dL (7–21)
  • Lactic acid 1.7 mmol/L (0.5–2.2)
  • White blood cell count 14.34 × 109/L (3.70–11.0).

Blood cultures were negative. Peritoneal fluid analysis showed a white blood cell count of 1.2 × 109/L (reference range < 0.5 × 109/L) with 89% neutrophils, and an amylase level less than 3 U/L (reference range < 100). Fluid cultures were positive for coagulase-negative staphylococci and Staphylococcus epidermidis.

Figure 1. Computed tomography showed diffuse parietal and visceral peritoneal calcifications encasing the small-bowel loops (arrows), consistent with encapsulating peritoneal sclerosis.
Computed tomography (CT) showed diffuse parietal and visceral peritoneal calcifications encasing the small-bowel loops, consistent with encapsulating peritoneal sclerosis (Figure 1). His peritoneal dialysis catheter was removed, and he was transitioned to hemodialysis. He was discharged on a course of antibiotics and was started on prednisone and tamoxifen.

Figure 2. Several months later, computed tomography showed dilated small-bowel loops indicative of small-bowel obstruction (red arrows) and pneumoperitoneum (yellow arrow).
He presented again a few months later with abdominal pain. At that time, CT (Figure 2) demonstrated dilated small-bowel loops indicative of small-bowel obstruction and pneumoperitoneum consistent with bowel perforation. He declined surgical treatment and was referred for hospice care.

CAUSES AND CLINICAL FEATURES

Encapsulating peritoneal sclerosis is a devastating complication of peritoneal dialysis, occurring in 3% of patients on peritoneal dialysis. The mortality rate is above 40%.1,2 It is characterized by an initial inflammatory phase followed by extensive intraperitoneal fibrosis and encasement of bowel. Causes include prolonged exposure to peritoneal dialysis or glucose degradation products, a history of severe peritonitis, use of acetate as a dialysate buffer, and reaction to medications such as beta-blockers.3

Clinical features result from inflammation, ileus, and peritoneal adhesions and include abdominal pain, nausea, and vomiting. A high peritoneal transport rate, which often heralds development of encapsulating peritoneal sclerosis, leads to failure of ultrafiltration and to fluid retention.

CT is recommended for diagnosis and demonstrates peritoneal calcification with bowel thickening and dilation.

TREATMENT

Treatment entails stopping peritoneal dialysis, changing to hemodialysis, bowel rest, and corticosteroids. Successful treatment has been reported with a combination of corticosteroids and azathioprine.4,5 A retrospective study showed that adding the antifibrotic agent tamoxifen was associated with a decrease in the mortality rate.6 Bowel obstruction is a common complication, and surgery may be indicated. Enterolysis is a new surgical technique that has shown improved outcomes.7         

References
  1. Kawaguchi Y, Saito A, Kawanishi H, et al. Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures. Perit Dial Int 2005; 25(suppl 4):S83–S95. pmid:16300277
  2. Lee HY, Kim BS, Choi HY, et al. Sclerosing encapsulating peritonitis as a complication of long-term continuous ambulatory peritoneal dialysis in Korea. Nephrology (Carlton) 2003; 8(suppl 2):S33–S39. doi:10.1046/J.1440-1797.8.S.11.X
  3. Kawaguchi Y, Tranaeus A. A historical review of encapsulating peritoneal sclerosis. Perit Dial Int 2005; 25(suppl 4):S7–S13. pmid:16300267
  4. Martins LS, Rodrigues AS, Cabrita AN, Guimaraes S. Sclerosing encapsulating peritonitis: a case successfully treated with immunosuppression. Perit Dial Int 1999; 19(5):478–481. pmid:11379862
  5. Wong CF, Beshir S, Khalil A, Pai P, Ahmad R. Successful treatment of encapsulating peritoneal sclerosis with azathioprine and prednisolone. Perit Dial Int 2005; 25(3):285–287. pmid:15981777
  6. Korte MR, Fieren MW, Sampimon DE, Lingsma HF, Weimar W, Betjes MG; investigators of the Dutch Multicentre EPS Study. Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study. Nephrol Dial Transplant 2011; 26(2):691–697. doi:10.1093/ndt/gfq362
  7. Kawanishi H, Watanabe H, Moriishi M, Tsuchiya S. Successful surgical management of encapsulating peritoneal sclerosis. Perit Dial Int 2005; 25(suppl 4):S39–S47. pmid:16300271
References
  1. Kawaguchi Y, Saito A, Kawanishi H, et al. Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures. Perit Dial Int 2005; 25(suppl 4):S83–S95. pmid:16300277
  2. Lee HY, Kim BS, Choi HY, et al. Sclerosing encapsulating peritonitis as a complication of long-term continuous ambulatory peritoneal dialysis in Korea. Nephrology (Carlton) 2003; 8(suppl 2):S33–S39. doi:10.1046/J.1440-1797.8.S.11.X
  3. Kawaguchi Y, Tranaeus A. A historical review of encapsulating peritoneal sclerosis. Perit Dial Int 2005; 25(suppl 4):S7–S13. pmid:16300267
  4. Martins LS, Rodrigues AS, Cabrita AN, Guimaraes S. Sclerosing encapsulating peritonitis: a case successfully treated with immunosuppression. Perit Dial Int 1999; 19(5):478–481. pmid:11379862
  5. Wong CF, Beshir S, Khalil A, Pai P, Ahmad R. Successful treatment of encapsulating peritoneal sclerosis with azathioprine and prednisolone. Perit Dial Int 2005; 25(3):285–287. pmid:15981777
  6. Korte MR, Fieren MW, Sampimon DE, Lingsma HF, Weimar W, Betjes MG; investigators of the Dutch Multicentre EPS Study. Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study. Nephrol Dial Transplant 2011; 26(2):691–697. doi:10.1093/ndt/gfq362
  7. Kawanishi H, Watanabe H, Moriishi M, Tsuchiya S. Successful surgical management of encapsulating peritoneal sclerosis. Perit Dial Int 2005; 25(suppl 4):S39–S47. pmid:16300271
Issue
Cleveland Clinic Journal of Medicine - 85(5)
Issue
Cleveland Clinic Journal of Medicine - 85(5)
Page Number
352, 354
Page Number
352, 354
Publications
Cleveland Clinic Journal of Medicine
Publications
Cleveland Clinic Journal of Medicine
Topics
Nephrology
Gastroenterology
Imaging
Article Type
Article
Display Headline
An unusual complication of peritoneal dialysis
Display Headline
An unusual complication of peritoneal dialysis
Legacy Keywords
peritoneal dialysis, end-stage renal disease, ESRD, encapsulating peritoneal sclerosis, computed tomography, CT, Mohamad Hanouneh, Pranav Damera, Mehrdad Fetrat, Duvuru Geetha
Legacy Keywords
peritoneal dialysis, end-stage renal disease, ESRD, encapsulating peritoneal sclerosis, computed tomography, CT, Mohamad Hanouneh, Pranav Damera, Mehrdad Fetrat, Duvuru Geetha
Sections
The Clinical Picture
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Wed, 04/25/2018 - 12:00
Un-Gate On Date
Wed, 04/25/2018 - 12:00
Use ProPublica
CFC Schedule Remove Status
Wed, 04/25/2018 - 12:00
Teaser Media
Article PDF Media
Subscribe to Duvuru Geetha, MD